84-3675-44 PARK2 (Juvenile Parkinson Disease Autosomal Recessive 2, Parkinson Disease Autosomal Recessive 2, PARK 2, PARK-2, Parkin) (APC) 100ul 301444-APC
特徴
- Mutations in the gene, Parkin (PARK2), appear to be responsible for the pathogenesis of autosomal recessive juvenile Parkinsonism.
- Parkin plays a role in the ubiquitin-mediated proteolytic pathway by removal and/or detoxification of abnormally folded or damaged protein.
- Loss of this ubiquitin ligase activity appears to be the mechanism underlying pathogenesis of Parkin.
- Applications:Suitable for use in Immunoprecipitation and Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:250-1:1000Immunoprecipitation: 1:250-1:1000Optimal dilutions to be determined by the researcher.
- Storage and Stability:Store product at 4°C in the dark.
- DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
- Dilute required amount only prior to immediate use.
- Further dilutions can be made in assay buffer.
- Caution: APC conjugates are sensitive to light.
- For maximum recovery of product, centrifuge the original vial prior to removing the cap.
- Note: Applications are based on unconjugated antibody.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide and a stabilizer. Labeled with Allophycocyanin (APC).
- Specificity:Recognizes human Parkin.
- Isotype:IgG
- Calc Applications Abbrev:IP WB
- Calc Crossreactivity:Hu
- Immunogen:Residues aa62-80, DQQSIVHIVQRPWRKGQEM, of 52kD human Parkin.
- Shelf Life:1year
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]